A- A A+

Associated Factors of Maintenance in Patients under Treatment with Methadone: A Comprehensive Systematic Review and Meta-Analysis.

Farmani F, Farhadi H, Mohammadi Y.

Addict Health. 2018 Jan;10(1):41-51. doi: 10.22122/ahj.v10i1.488. Review.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312561/

Webinar: USA. Improving Clinical Quality in Methadone Treatment: Results of a 2-Year Pilot (on demand)

Description

There are more methadone programs in the U.S. today than there were five years ago. In fact, the methadone treatment industry grew more in the past four years than it has in the past two decades. That’s important in an opioid epidemic.

But IRETA has been working on another important aspect of methadone services: quality. In this webinar, we’ll describe our two-year clinical quality improvement project with a western Pennsylvania methadone program, which finished in October 2018. We’ll discuss lessons learned, client satisfaction, and ways to implement these ideas in your area. (IRETA - Institute for Research, Education and Training in Addictions, USA, 24.01.2019)

https://ireta.org/resources/improving-clinical-quality-in-methadone-treatment-results-of-a-2-year-pilot

BeTrAD - Better Treatment for Ageing Drug User

The main objective of the project is to provide adult trainers and organisations in the drug help system, in geriatric institutions and local governments with tools and models of good practice, which create adult learning opportunities for the establishment and improvement of services for ageing drug user.

High priority is given to involve drug user and their representatives in the development and implementation of project results. (Mit Trainig Curriculum, Toolbox, Best Practice Collection u.a. (englischsprachig)) (Fondation Jugend- an Drogenhëllef für die europäische Arbeitsgruppe, Luxemburg, funded by the European Union, Project Number: 2016-1-Lu01-KA 204-013837, 2018)

http://www.betrad.eu/

Behavioral and Clinical Characteristics of American Indian/Alaska Native Adults in HIV Care - Medical Monitoring Project, United States, 2011-2015.

Baugher AR, Beer L, Bradley HM, Evans ME, Luo Q, Shouse RL.

MMWR Morb Mortal Wkly Rep. 2019 Jan 4;67(5152):1405-1409. doi: 10.15585/mmwr.mm675152a1.

https://www.cdc.gov/mmwr/volumes/67/wr/mm675152a1.htm

USA. Racial disparities in opioid treatment completion across U.S. cities

When policymakers decide how to help more people with opioid use disorder enter and finish treatment, race is a necessary factor to consider. In the United States, black and Hispanic people with substance use disorders experience more barriers to receiving treatment and complete treatment less often compared to white people. This information is presented on a national level and doesn’t communicate important regional variations in treatment services and patient demographics that likely relate to completion rates. This week, STASH reviews a study by Gerald Stahler and Jeremy Mennis that examined how completion of treatment for opioid use disorder differs by race across U.S. cities. (STASH, Vol.15(1) – Division on Addiction, Cambridge Health Alliance, a Harvard Medical School teaching hospital, USA, 22.01.2019)

https://www.basisonline.org/2019/01/racial-disparities-opioid-treatment-us-cities.html

Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice

Ide Delargy, Des Crowley and Marie Claire Van Hout 

Harm Reduction Journal 2019, 16:5, doi.org/10.1186/s12954-018-0272-4

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-018-0272-4

USA. How OTPs Can Help Pain Patients With OUDS: SAMHSA

Can opioid treatment programs (OTPs) help pain patients who no longer need opioids for pain? Absolutely, says Elinore F. McCance-Katz, MD, PhD, assistant secretary for mental health and substance use at the Department of Health and Human Services (HHS). “For overuse and misuse of pain medications over time, which may have been initiated for a pain condition—I definitely think there’s a role for OTPs in this,” she told AT Forum. (AT Forum, 18.01.2019)

http://atforum.com/2019/01/otps-help-pain-patients-ouds-samhsa/

USA. The “Three-Day Rule” Needs To Be Extended to Allow Longer Treatment With Methadone or Buprenorphine

In 2017, Gail Groves Scott, MPH, manager of the Substance Use Disorders Institute at the University of the Sciences in Philadelphia, wrote a passionate piece in the Philadelphia Inquirerabout the importance of expanding existing Drug Enforcement Administration (DEA) rules to expand and relax hospital regulations. Ms. Scott sought to remove the “three-day rule,” which limits treatment with methadone or buprenorphine for an opioid use disorder (OUD) to three days. A related rule requires hospitals to say whether the opioid addiction diagnosis is primary or secondary to other diseases for which the patient is being treated at the hospital, Ms. Scott wrote. (AT Forum, 18.01.2019)

http://atforum.com/2019/01/three-day-rule-allow-longer-treatment/

USA. Fraction of U.S. Outpatient Treatment Centers Offer Medication for Opioid Addiction

Study finds that most substance use disorder treatment facilities still do not offer medication treatment for opioid use disorder. (Johns Hopkins Bloomberg School of Public Health, USA, 15.01.2019)

https://www.jhsph.edu/news/news-releases/2019/fraction-of-us-outpatient-treatment-centers-offer-medication-for-opioid-addiction.html

USA. USING MEDICATION ASSISTED TREATMENT TO TREAT OPIOID USE DISORDER: LEARNING FROM PAST EXPERIENCE TO GUIDE POLICY

MARK W. PARRINO, M.P.A., PRESIDENT

AATOD - The American Association for the Treatment of Opioid Dependence, 2019

http://www.aatod.org/wp-content/uploads/2019/01/2019-Policy-Paper-4.pdf

Emergency Department and Hospital Care for Opioid Use Disorder: Implementation of Statewide Standards in Rhode Island, 2017-2018.

Samuels EA, McDonald JV, McCormick M, Koziol J, Friedman C, Alexander-Scott N.

Am J Public Health. 2018 Dec 20:e1-e4. doi: 10.2105/AJPH.2018.304847.

https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2018.304847

Rhode Island Domestic Violence Shelter Policies, Practices, and Experiences Pertaining to Survivors With Opioid Use Disorder: Results of a Qualitative Study.

Rothman EF, Stone R, Bagley SM.

Subst Abuse. 2018 Nov 27;12:1178221818812895. doi: 10.1177/1178221818812895. eCollection 2018.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259060/

Kanada. Vancouver looks to pioneer 'safe supply' for hard drug users

"Nowhere else that I'm aware of in the world are they advocating rapid, low-barrier access to pharmaceutical drugs." (Vancouver Sun, Kanada, 20.12.2018)

https://vancouversun.com/news/local-news/vancouver-looks-to-pioneer-safe-supply-for-hard-drug-users

KANADA / Vancouver. Mayor’s Overdose Emergency Task Force - Recommendations for Immediate Action on the Overdose Crisis

(City of Vancouver, 20.12.2018)

https://council.vancouver.ca/20181220/documents/spec1.pdf

You can't do this job when you are sober: Heroin use among female sex workers and the need for comprehensive drug treatment programming in Kenya.

Syvertsen JL, Agot K, Ohaga S, Bazzi AR.

Drug Alcohol Depend. 2018 Nov 13;194:495-499. doi: 10.1016/j.drugalcdep.2018.10.019.

https://www.sciencedirect.com/science/article/pii/S0376871618307993

State variation in opioid treatment policies and opioid-related hospital readmissions.

Blanchard J, Weiss AJ, Barrett ML, McDermott KW, Heslin KC.

BMC Health Serv Res. 2018 Dec 17;18(1):971. doi: 10.1186/s12913-018-3703-8.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296089/

Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services.

Moran L, Keenan E, Elmusharaf K.

BMC Health Serv Res. 2018 Nov 29;18(1):911. doi: 10.1186/s12913-018-3717-2.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267916/

Treatment of an HIV-affected adolescent with heroin dependence in a low-income country: A clinical case study from Zambia.

Akiba C, Kane JC, Skavenski van Wyk S, Paul R, Mukunta C, Murray LK.

Addict Behav Rep. 2018 Sep 25;8:170-175. doi: 10.1016/j.abrep.2018.09.003.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251977/

Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.

Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, Harris AHS.

Addict Sci Clin Pract. 2018 Dec 13;13(1):25. doi: 10.1186/s13722-018-0127-z.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293521/

USA. The Treatment Gap. In Rehab, ‘Two Warring Factions’: Abstinence vs. Medication

A reluctant evolution is taking place in residential drug treatment for opioid addiction. Here’s a look at one center’s wary shift. (New York Times, 29.12.2018)

https://www.nytimes.com/2018/12/29/health/opioid-rehab-abstinence-medication.html

UK. End of life care for people with problematic substance use

This website offers resources developed from a two year research programme on end of life care for people with alcohol and other drug problems. Funded by the Big Lottery Fund between 2016 and 2018, the research programme was the first of its kind to explore current practice and service experience from a range of perspectives. (Manchester Metropolitan University, Dezember 2018)

https://endoflifecaresubstanceuse.com/

USA. Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder

reSET-O™ is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder

Pear Therapeutics is leading the development of a new therapeutic class with two FDA-authorized PDTs and a robust pipeline of therapeutics across disease areas

Sandoz will lead U.S. commercial launch, anticipated in coming days in Q4

As part of broader Novartis digital revolution, Sandoz aims to increase patient engagement and improve access to treatment through digital solutions. (Pear Therapeutics, 10.12.2018)

https://peartherapeutics.com/sandoz-inc-and-pear-therapeutics-obtain-fda-clearance-for-reset-o-to-treat-opioid-use-disorder/

Irland. “Just Maintaining the Status Quo”? The experiences of Long-term Participants in Methadone Maintenance Treatment 

Paula Mayock, Shane Butler, Daniel Hoey

Dun Laoghaire Rathdown Drug and Alcohol Task Force, Dublin Irland, 2018

http://www.dlrdrugtaskforce.ie/web-version-of-report.pdf

Australien. 'Unacceptable': $1 billion needed to fix health crisis

(...) A huge coalition of health and welfare organisations have joined forces to call out this “unacceptable” situation. They estimate up to half a million Australians are unable to access treatment for drug and alcohol problems every year, causing a large secondary drag on the health and justice systems. (SMH – Sydney Morning Herald, Australien, 14.12.2018)

https://www.smh.com.au/politics/federal/unacceptable-1-billion-needed-to-fix-health-crisis-20181213-p50m0b.html

Extension for Community Healthcare Outcomes (ECHO) as a tool for continuing medical education on opioid use disorder and comorbidities.

Agley, J., Adams, Z. W., and Hulvershorn, L. A. (2018) 

Addiction, First published: 05 November 2018, doi.org/10.1111/add.14494

https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.14494

Cost of pharmacotherapy for opioid use disorders following inpatient detoxification.

McCollister KE, Leff JA, Yang X, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR, Murphy SM.

Am J Manag Care. 2018 Nov;24(11):526-531.

https://www.ajmc.com/journals/issue/2018/2018-vol24-n11/cost-of-pharmacotherapy-for-opioid-use-disorders-following-inpatient-detoxification

The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic

Viktor Mravčík, Barbara Janíková, Barbora Drbohlavová, Petr Popov and Alessandro Pirona

Harm Reduction Journal2018, 15:60, doi.org/10.1186/s12954-018-0268-0

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-018-0268-0

Griechenland. ‘Public health’, ‘social solidarity’ and a modern Greek tragedy…

We are writing these lines in November 2018; 6 years after the Greek Ministry of Public Health and Social Solidary first issued Health Regulation No GY/39A, which gave the Greek police the power to detain drug users, amongst other groups, for forced HIV testing and compulsory hospitalisation and treatment (where deemed ‘appropriate’). The Health Regulation was issued amidst what was deemed a public health emergency. For the first time, the number of new HIV transmissions among people who inject drugs had exceeded the number of new cases reported among men who have sex with men.

Dr. Maria Fotopoulou, Sofia Galinaki and Chara-Ismini Papageorgiou in: IDPC - International Drug Policy Consortium, 19.11.2018.

https://idpc.net/blog/2018/11/public-health-social-solidarity-and-a-modern-greek-tragedy

Neuseeland. He Ara Oranga - Report of the Government Inquiry into Mental Health and Addiction 

(...) It’s time to build a new mental health and addiction system on the existing foundations to provide a continuum of care and support. We will always have a special responsibility to those most in need. They must remain the priority. But we need to expand access so that people in serious distress – the ‘missing middle’ who currently miss out – can get the care and support they need to manage and recover. (Government Inquiry into Mental Health and Addiction, November 2018) (He Ara Oranga translates as Pathways to Wellness)

www.mentalhealth.inquiry.govt.nz/inquiry-report/

More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic.

Friedmann PD, Suzuki J.

Addict Sci Clin Pract. 2017 Nov 15;12(1):29. doi: 10.1186/s13722-017-0092-y. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688652/